Pramipexole dihydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
50742-331 -
Package NDC
50742-331-30 -
Application number
ANDA213444 -
SPL ID
74c3457e-079c-4b2b-bae4-3f148540a27a -
SPL set ID
1d2b1d2c-ae22-424a-bad7-ce24a817b042 -
UNII
3D867NP06J -
RxCUI
901534 -
RxCUI
901541 -
RxCUI
901546 -
RxCUI
901550 -
RxCUI
901555 -
RxCUI
1114479 -
RxCUI
1114485
What the source publishes
- Labeler
- Ingenus Pharmaceuticals, LLC
- Active ingredients
- Pramipexole dihydrochloride
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Pramipexole dihydrochloride",
"splId": "74c3457e-079c-4b2b-bae4-3f148540a27a",
"labels": [
{
"setId": "1d2b1d2c-ae22-424a-bad7-ce24a817b042",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1d2b1d2c-ae22-424a-bad7-ce24a817b042",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1d2b1d2c-ae22-424a-bad7-ce24a817b042"
}
],
"routes": [
"ORAL"
],
"labeler": "Ingenus Pharmaceuticals, LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-331-30)",
"package_ndc": "50742-331-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20220310"
}
],
"productId": "50742-331_74c3457e-079c-4b2b-bae4-3f148540a27a",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "50742-331",
"deaSchedule": null,
"genericName": "Pramipexole dihydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "PRAMIPEXOLE DIHYDROCHLORIDE",
"strength": ".375 mg/1"
}
],
"applicationNumber": "ANDA213444",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220310",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0350742337309",
"0350742336302",
"0350742334308",
"0350742335305"
],
"unii": [
"3D867NP06J"
],
"rxcui": [
"901534",
"901541",
"901546",
"901550",
"901555",
"1114479",
"1114485"
],
"spl_set_id": [
"1d2b1d2c-ae22-424a-bad7-ce24a817b042"
],
"manufacturer_name": [
"Ingenus Pharmaceuticals, LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:50742-331_74c3457e-079c-4b2b-bae4-3f148540a27a"